Evaluation  ||| S:0 E:11 ||| NN
of  ||| S:11 E:14 ||| IN
the  ||| S:14 E:18 ||| DT
inadequate  ||| S:18 E:29 ||| JJ
diagnostic  ||| S:29 E:40 ||| JJ
rate  ||| S:40 E:45 ||| NN
of  ||| S:45 E:48 ||| IN
ultrasound  ||| S:48 E:59 ||| FW
guided  ||| S:59 E:66 ||| FW
fine  ||| S:66 E:71 ||| FW
needle  ||| S:71 E:78 ||| FW
aspiration  ||| S:78 E:89 ||| FW
cytology  ||| S:89 E:98 ||| FW
inthyroid  ||| S:98 E:108 ||| FW
calcified  ||| S:108 E:118 ||| FW
nodules  ||| S:118 E:126 ||| FW
To  ||| S:126 E:129 ||| TO
evaluate  ||| S:129 E:138 ||| VB
the  ||| S:138 E:142 ||| DT
inadequate  ||| S:142 E:153 ||| JJ
diagnostic  ||| S:153 E:164 ||| JJ
rate  ||| S:164 E:169 ||| NN
of  ||| S:169 E:172 ||| IN
ultrasound  ||| S:172 E:183 ||| FW
guided  ||| S:183 E:190 ||| FW
fine  ||| S:190 E:195 ||| FW
needle  ||| S:195 E:202 ||| FW
aspiration  ||| S:202 E:213 ||| FW
cytology  ||| S:213 E:222 ||| FW
( ||| S:222 E:223 ||| -LRB-
USFNAC ||| S:223 E:229 ||| NNP
)  ||| S:229 E:231 ||| -RRB-
in  ||| S:231 E:234 ||| IN
thyroid  ||| S:234 E:242 ||| CD
calcified  ||| S:242 E:252 ||| CD
nodules.  ||| S:252 E:261 ||| CD
208  ||| S:261 E:265 ||| CD
thyroid  ||| S:265 E:273 ||| NNS
calcified  ||| S:273 E:283 ||| VBP
nodules  ||| S:283 E:291 ||| VBN
in  ||| S:291 E:294 ||| IN
202  ||| S:294 E:298 ||| CD
patients  ||| S:298 E:307 ||| NNS
were  ||| S:307 E:312 ||| VBD
retrospective  ||| S:312 E:326 ||| JJ
analyzed ||| S:326 E:334 ||| NN
,  ||| S:334 E:336 ||| ,
and  ||| S:336 E:340 ||| CC
all  ||| S:340 E:344 ||| DT
of  ||| S:344 E:347 ||| IN
the  ||| S:347 E:351 ||| DT
nodules  ||| S:351 E:359 ||| NN
were  ||| S:359 E:364 ||| VBD
acquired  ||| S:364 E:373 ||| VBN
cytological  ||| S:373 E:385 ||| JJ
diagnosis ||| S:385 E:394 ||| NN
.  ||| S:394 E:396 ||| .
There  ||| S:396 E:402 ||| EX
was  ||| S:402 E:406 ||| VBD
no  ||| S:406 E:409 ||| DT
significant  ||| S:409 E:421 ||| JJ
complication  ||| S:421 E:434 ||| NN
in  ||| S:434 E:437 ||| IN
the  ||| S:437 E:441 ||| DT
all  ||| S:441 E:445 ||| RB
208  ||| S:445 E:449 ||| CD
thyroid  ||| S:449 E:457 ||| CD
calcified  ||| S:457 E:467 ||| CD
nodules ||| S:467 E:474 ||| NNS
.  ||| S:474 E:476 ||| .
The  ||| S:476 E:480 ||| DT
inadequate  ||| S:480 E:491 ||| JJ
diagnostic  ||| S:491 E:502 ||| JJ
rate  ||| S:502 E:507 ||| NN
was  ||| S:507 E:511 ||| VBD
25.5 ||| S:511 E:515 ||| CD
%  ||| S:515 E:517 ||| NN
in  ||| S:517 E:520 ||| IN
thyroid  ||| S:520 E:528 ||| JJ
calcified  ||| S:528 E:538 ||| JJ
nodules ||| S:538 E:545 ||| NN
.  ||| S:545 E:547 ||| .
The  ||| S:547 E:551 ||| DT
inadequate  ||| S:551 E:562 ||| JJ
diagnostic  ||| S:562 E:573 ||| JJ
rates  ||| S:573 E:579 ||| NNS
in  ||| S:579 E:582 ||| IN
micro  ||| S:582 E:588 ||| JJ
calcifications  ||| S:588 E:603 ||| NN
,  ||| S:603 E:605 ||| ,
macro  ||| S:605 E:611 ||| JJ
calcifications  ||| S:611 E:626 ||| NN
and  ||| S:626 E:630 ||| CC
circumjacent  ||| S:630 E:643 ||| JJ
arc  ||| S:643 E:647 ||| JJ
calcifications  ||| S:647 E:662 ||| NN
were  ||| S:662 E:667 ||| VBD
16.0 ||| S:667 E:671 ||| CD
% ||| S:671 E:672 ||| NN
,  ||| S:672 E:674 ||| ,
26.4 ||| S:674 E:678 ||| CD
%  ||| S:678 E:680 ||| NN
and  ||| S:680 E:684 ||| CC
76.5 ||| S:684 E:688 ||| CD
% ||| S:688 E:689 ||| NN
.  ||| S:689 E:691 ||| .
The  ||| S:691 E:695 ||| DT
inadequate  ||| S:695 E:706 ||| JJ
diagnostic  ||| S:706 E:717 ||| JJ
rate  ||| S:717 E:722 ||| NN
in  ||| S:722 E:725 ||| IN
circumjacent  ||| S:725 E:738 ||| JJ
arc  ||| S:738 E:742 ||| JJ
calcifications  ||| S:742 E:757 ||| NN
were  ||| S:757 E:762 ||| VBD
higher  ||| S:762 E:769 ||| JJR
than  ||| S:769 E:774 ||| IN
those  ||| S:774 E:780 ||| DT
in  ||| S:780 E:783 ||| IN
micro  ||| S:783 E:789 ||| JJ
calcifications  ||| S:789 E:804 ||| NN
and  ||| S:804 E:808 ||| CC
macro  ||| S:808 E:814 ||| JJ
calcifications  ||| S:814 E:829 ||| NNS
( ||| S:829 E:830 ||| -LRB-
P  ||| S:830 E:832 ||| NNP
< ||| S:832 E:834 ||| SYM
0.01 ||| S:834 E:838 ||| CD
)  ||| S:838 E:840 ||| -RRB-
,  ||| S:840 E:842 ||| ,
and  ||| S:842 E:846 ||| CC
the  ||| S:846 E:850 ||| DT
rates  ||| S:850 E:856 ||| NNS
were  ||| S:856 E:861 ||| VBD
no  ||| S:861 E:864 ||| DT
significance  ||| S:864 E:877 ||| NN
in  ||| S:877 E:880 ||| IN
micro  ||| S:880 E:886 ||| JJ
calcifications  ||| S:886 E:901 ||| NN
and  ||| S:901 E:905 ||| CC
macro  ||| S:905 E:911 ||| JJ
calcifications ||| S:911 E:925 ||| NN
.  ||| S:925 E:927 ||| .
There  ||| S:927 E:933 ||| EX
was  ||| S:933 E:937 ||| VBD
no  ||| S:937 E:940 ||| DT
statistical  ||| S:940 E:952 ||| JJ
significance  ||| S:952 E:965 ||| NN
in  ||| S:965 E:968 ||| IN
different  ||| S:968 E:978 ||| JJ
size  ||| S:978 E:983 ||| NN
of  ||| S:983 E:986 ||| IN
thyroid  ||| S:986 E:994 ||| JJ
calcified  ||| S:994 E:1004 ||| JJ
nodules ||| S:1004 E:1011 ||| NN
.  ||| S:1011 E:1013 ||| .
The  ||| S:1013 E:1017 ||| DT
inadequate  ||| S:1017 E:1028 ||| JJ
diagnostic  ||| S:1028 E:1039 ||| JJ
rate  ||| S:1039 E:1044 ||| NN
in  ||| S:1044 E:1047 ||| IN
circumjacent  ||| S:1047 E:1060 ||| JJ
arc  ||| S:1060 E:1064 ||| JJ
calcifications  ||| S:1064 E:1079 ||| NN
was  ||| S:1079 E:1083 ||| VBD
higher ||| S:1083 E:1089 ||| JJR
,  ||| S:1089 E:1091 ||| ,
and  ||| S:1091 E:1095 ||| CC
should  ||| S:1095 E:1102 ||| MD
to  ||| S:1102 E:1105 ||| TO
avoid  ||| S:1105 E:1111 ||| VB
USFNAC  ||| S:1111 E:1118 ||| NNP
in  ||| S:1118 E:1121 ||| IN
these  ||| S:1121 E:1127 ||| DT
nodules ||| S:1127 E:1134 ||| NN
.  ||| S:1134 E:1136 ||| .
